Optimal two-stage designs for clinical trials based on safety and efficacyTHALL, Peter F; CHENG, Su-Chun.Statistics in medicine. 2001, Vol 20, Num 7, pp 1023-1032, issn 0277-6715Article

Evaluating joint effects of induction―salvage treatment regimes on overall survival in acute leukaemiaWAHED, Abdus S; THALL, Peter F.Applied statistics. 2013, Vol 62, Num 1, pp 67-83, issn 0035-9254, 17 p.Article

Some geometric methods for constructing decision criteria based on two-dimensional parametersTHALL, Peter F.Journal of statistical planning and inference. 2008, Vol 138, Num 2, pp 516-527, issn 0378-3758, 12 p.Article

Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknownYING YUAN; THALL, Peter F; WOLFF, Johannes E et al.Applied statistics. 2012, Vol 61, Num 1, pp 135-149, issn 0035-9254, 15 p.Article

Dose-finding based on multiple toxicities in a soft tissue sarcoma trialBEKELE, B. Nebiyou; THALL, Peter F.Journal of the American Statistical Association. 2004, Vol 99, Num 465, pp 26-35, issn 0162-1459, 10 p.Article

Practical Bayesian adaptive randomisation in clinical trialsTHALL, Peter F; KYLE WATHEN, J.European journal of cancer (1990). 2007, Vol 43, Num 5, pp 859-866, issn 0959-8049, 8 p.Article

Selecting therapeutic strategies based on efficacy and death in multicourse clinical trialsTHALL, Peter F; SUNG, Hsi-Guang; ESTEY, Elihu H et al.Journal of the American Statistical Association. 2002, Vol 97, Num 457, pp 29-39, issn 0162-1459Article

Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remissionFADERL, Stefan; THALL, Peter F; KANTARJIAN, Hagop M et al.British journal of haematology. 2002, Vol 117, Num 4, pp 869-874, issn 0007-1048Article

A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancerMORITA, Satoshi; THALL, Peter F; NEBIYOU BEKELE, B et al.Applied statistics. 2010, Vol 59, Num 1, pp 19-34, issn 0035-9254, 16 p.Article

A Randomized Phase 2 Trial Comparing 3-Hour Versus 96-Hour Infusion Schedules of Paclitaxel for the Treatment of Metastatic Breast CancerMOULDER, Stacy L; HOLMES, Frankie A; TOLCHER, Anthony W et al.Cancer. 2010, Vol 116, Num 4, pp 814-821, issn 0008-543X, 8 p.Article

Improved tolerability and quality of life with maintained efficacy using twice-daily low-dose interferon-α-2b : Results of a randomized phase II trial of low-dose versus intermediate-dose interferon-α-2b in patients with metastatic renal cell carcinomaTANNIR, Nizar M; COHEN, Lorenzo; XUEMEI WANG et al.Cancer. 2006, Vol 107, Num 9, pp 2254-2261, issn 0008-543X, 8 p.Article

Durable Remission With Salvage Second Autotransplants in Patients With Multiple MyelomaSHAH, Nina; AHMED, Fraz; CHAMPLIN, Richard et al.Cancer. 2012, Vol 118, Num 14, pp 3549-3555, issn 0008-543X, 7 p.Article

Induction Treatment for Diffuse Intrinsic Pontine Glioma, Experience of M.D. Anderson Cancer CenterWOLFF, Johannes E; RYTTING, Michael; CHANG, Eric L et al.Anticancer research. 2011, Vol 31, Num 6, pp 2265-2269, issn 0250-7005, 5 p.Article

A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expressionGILES, Francis J; NEBIYOU BEKELE, B; THALL, Peter et al.British journal of haematology. 2003, Vol 121, Num 4, pp 578-585, issn 0007-1048, 8 p.Article

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypesTHALL, Peter F; WATHEN, J. Kyle; BEKELE, B. Nebiyou et al.Statistics in medicine. 2003, Vol 22, Num 5, pp 763-780, issn 0277-6715, 18 p.Article

Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLESTEY, Elihu H; THALL, Peter F; XUEMEI WANG et al.Blood. 2003, Vol 102, Num 9, pp 3097-3099, issn 0006-4971, 3 p.Article

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinomaDALIANI, Danai D; PAPANDREOU, Christos N; THALL, Peter F et al.Cancer. 2002, Vol 95, Num 4, pp 758-765, issn 0008-543XArticle

A Possible Association Between Aprotinin and Improved Survival After Radical Surgery for MesotheliomaNORMAN, Peter H; THALL, Peter F; PURUGGANAN, Ronaldo V et al.Cancer. 2009, Vol 115, Num 4, pp 833-841, issn 0008-543X, 9 p.Article

Results of a phase II study with doxorubicin, etoposide, and cisplatin in Patients with fully characterized small-cell carcinoma of the prostatePAPONDREOU, Christos N; DALIANI, Danai D; THALL, Peter F et al.Journal of clinical oncology. 2002, Vol 20, Num 14, pp 3072-3080, issn 0732-183XArticle

Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal CancerLIN, Steven H; LU WANG; MYLES, Bevan et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 5, pp 1078-1085, issn 0360-3016, 8 p.Article

Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancerMILLIKAN, Randall; THALL, Peter F; LEE, Sang-Joon et al.Journal of clinical oncology. 2003, Vol 21, Num 5, pp 878-883, issn 0732-183X, 6 p.Article

Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two Cancer centers: Chemotherapy-associated outcomesCORMIER, Janice N; XUELIN HUANG; PISTERS, Peter W. T et al.Journal of clinical oncology. 2004, Vol 22, Num 22, pp 4567-4574, issn 0732-183X, 8 p.Article

Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blastsESTEY, Elihu H; THALL, Peter F; CORTES, Jorge E et al.Blood. 2001, Vol 98, Num 13, pp 3575-3583, issn 0006-4971Article

Employing thetreatment-free interval of intermittent androgen ablation to screen candidate prostate cancertherapiesSHIFENG MAO; DALIANI, Danai D; KIM, Jeri et al.The Prostate. 2007, Vol 67, Num 15, pp 1677-1685, issn 0270-4137, 9 p.Article

Page / 2